Navigation Links
Spending more for lung cancer treatment did not substantially increase patients' lives
Date:10/21/2007

A new study finds that survival for elderly patients with lung cancer has changed little despite large increases in healthcare expenditures for lung cancer treatment. The study by Harvard University, National Cancer Institute, and National Bureau of Economic Research researchers, published in the December 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society, finds that average life-expectancy rose by less than one month between 1983 and 1997, while costs rose by over $20,000 per patient.

Lung cancer remains the top cause of cancer death in the United States, with an estimated 160,390 deaths expected to occur in 2007.

The U.S. spends more than five billion dollars a year on detection, determining the disease severity, and treatment of lung cancer. This is a significant increase over the last few decades, mirroring similar increases in general healthcare spending over the same period. The one-year survival rate for lung cancer has increased slightly, from 37 percent in 1975-1979 to 42 percent in 2002, largely due to improvements in surgical techniques and combined therapies. However the five-year survival rate for all stages of lung cancer combined has remained relatively stable, and is currently only about 16 percent.

Dr. Rebecca Woodward and her colleagues linked and analyzed non-small cell lung cancer survival data from the National Cancer Institutes Surveillance, Epidemiology, and End Results (SEER) database and Medicare Parts A and B reimbursement data from the Continuous Medicare History Sample File (CMHSF) database. Their objective was to examine changes in treatment costs and outcomes for localized, regional and metastatic lung cancer from the early 1980s to the mid-1990s.

Cost-effectiveness, as measured by the cost of an additional year of life gained, was poor, with a high average cost of $403,142. While early stage cancer treatment was more cost-effective by conventional standards than treatments for advanced disease, the gains still were limited. When analyzed by disease severity, the cost per additional year gained for local and regional disease was $143,614 and 145,861, respectively. For metastatic cancer, the cost per additional year gained was $1,190,322.

Dr. Woodward and her co-authors conclude, The additional money spent on lung cancer treatment in the mid-1990s compared to in the early 1980s did not result in a favorable economic rate of return by conventional benchmarks.


'/>"/>

Contact: Amy Molnar
amolnar@wiley.com
John Wiley & Sons, Inc.
Source:Eurekalert

Related medicine news :

1. Risk of DVT for those spending long hours in front of computers
2. Jumping The Queue Has Left Hospital Suspending Transplantation
3. Stop spending on new treatments; allocate funds to improve the existing treatments.
4. More Spending Does Not Ensure Better Healthcare
5. Western Australian Government Spending Extra For Mental Health Services
6. Overspending in Hospitals to Lead to Cutbacks
7. Lowest Spending growth in US Medicaid
8. Variation in U.S. Healthcare Spending
9. G8 Members To Announce Plans To Increase HIV/AIDS Spending at Summit
10. Spending on Diabetes Drugs Soars in US
11. Coverage for Childrens Mental Illness Reduces Out-of-Pocket Spending
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... ... Medic CE , a Career Step company, is sponsoring a live, 1-hour ... Journal of Emergency Medical Services (JEMS). The free webinar, to be held on Wednesday, ... Duckworth, LP, a career fire captain as well as founder and director of the ...
(Date:5/24/2017)... ... May 24, 2017 , ... The CFOs included ... and health systems in the nation and help their organizations navigate the challenges ... and been instrumental in developing successful hospital and health system strategy. , Becker's ...
(Date:5/23/2017)... ... May 23, 2017 , ... Axiad IDS , a leading provider of ... has named the company a “Top 25 Cybersecurity Companies 2017.” Axiad IDS ... organizations simply and proactively address potential cybersecurity threats before they happen. The ...
(Date:5/23/2017)... , ... May 23, 2017 , ... ... technology and a 2017 Best in KLAS category winner, has named Daniel P. ... to extend and enhance its technology platform and product offerings,” says Justin Neece, ...
(Date:5/23/2017)... Las Vegas, NV (PRWEB) , ... May 23, ... ... with Significance Dental Specialists, are educating patients on peri-implantitis in Las ... new patients to receive a custom gum disease consultation and leading care for ...
Breaking Medicine News(10 mins):
(Date:5/3/2017)... 2017 A Catheterization Laboratory is an ... facility. Commonly referred to as cath lab, this ... imaging technology to give physicians visual access to ... spaces, a team of physicians perform life-saving procedures ... intervention, congenital heart defect closure, stenotic heart valves, ...
(Date:5/3/2017)... 3, 2017  Getinge, a leading global provider ... enhancement and cost efficiency within healthcare and life ... contemporary practice demonstrating that intra-aortic balloon counterpulsation (IABC) ... ill patients. The single-center, retrospective, observational study showed ... MEGA ® 50cc intra-aortic balloon (IAB) in ...
(Date:5/2/2017)... NEW YORK and LONDON ... leading distributor of market intelligence, MarketResearch.com is pleased to ... Reimbursement Consulting AB that allows for the marketing ... proprietary market analyses through the MarketResearch.com website. ... easy access to complete product descriptions and tables of ...
Breaking Medicine Technology: